Jupiter Life Line Hospitals Limited
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, TAVI/TAVR, and urology. It also operates hotel under the Fortune Park Lake City Hotel name in Thane. The company was incorporated in 2002 and is based in Mumbai, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Strong 5-year net profit CAGR of 38.3%
Concerns0
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 8 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ1.06 K Cr | β | βΉ185.00 Cr | β | β | 13.0% | 15.8% | 21.7% |
| Mar 2024 | βΉ915.00 Cr | β | βΉ152.00 Cr | β | β | 12.2% | 16.3% | 42.1% |
| Mar 2023 | βΉ787.00 Cr | β | βΉ107.00 Cr | β | β | 23.0% | 19.8% | 25.9% |
| Mar 2022 | βΉ657.00 Cr | β | βΉ85.00 Cr | β | β | 25.8% | 42.5% | 400.0% |
| Mar 2021 | βΉ461.00 Cr | β | βΉ17.00 Cr | β | β | 6.7% | -0.4% | -43.3% |
| Mar 2020 | βΉ463.00 Cr | β | βΉ30.00 Cr | β | β | 12.7% | 16.3% | 66.7% |
| Mar 2019 | βΉ398.00 Cr | β | βΉ18.00 Cr | β | β | 8.5% | 24.4% | -40.0% |
| Mar 2018 | βΉ320.00 Cr | β | βΉ30.00 Cr | β | β | 15.2% | β | β |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 1,138 |
| Total Expenses | 851 |
| EBIT / Operating Profit | 287 |
| OPM % | 25% |
| Other Income | 38 |
| Finance Costs | 13 |
| Depreciation & Amortisation | 57 |
| Profit Before Tax | 255 |
| Tax % | - |
| Net Profit / PAT | 192 |
| EPS (βΉ) | 29.23 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Jupiter Life Line Hospitals Limitedthis co. | βΉ8.88 K Cr | βΉ1.06 K Cr | 46.30 | 5.87 | 34.52 | 15.8% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |